| |||||||||
|
33%
agree
|
Few to no products in early development or testing |
|
0%
agree
|
The Plavix situation |
|
25%
agree
|
If a stock is "cheap" there has to be a reason why. |
![]()
|
|||||||||||||||||||||
| ||||||